Cite
HARVARD Citation
Yamamura, M. et al. (n.d.). 1622PHeat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors. Annals of oncology. p. . [Online].